No Data
No Data
Is Fulgent Genetics (NASDAQ:FLGT) Using Too Much Debt?
Express News | Fulgent Genetics Inc - Contract Value up to $99 Million Over Five Years
Fulgent Genetics Awarded Contract by the U.S. Department of Veterans Affairs to Provide Hereditary Cancer, Pharmacogenetic and Other Genetic Testing to Veterans1
Fulgent to Announce Third Quarter 2024 Financial Results on Friday, November 8, 2024
Fulgent Genetics, Inc. (NASDAQ:FLGT) Investors Are Less Pessimistic Than Expected
Those Who Invested in Fulgent Genetics (NASDAQ:FLGT) Five Years Ago Are up 107%
No Data
No Data
Silverbat : Buy at dips and hold for 192